The company has already demonstrated the value of its platform through successful collaborations with several leading pharmaceutical companies, focusing on multiple classes of drugs. The new funding will enable Zafrens to expand its capacity and...
Harbour BioMed a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology and immunology, announced that the National Medical Products Administration...
Avanzanite Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company advancing life-changing medicines for rare disease patients across Europe, announces today the appointment of Abdelghani (Abdel) Omari as its first-ever...
HOOKIPA Pharma Inc. a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer and serious infectious diseases, today announced that enrollment is complete in the Phase 1b clinical trial...
Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA) and a recognized leader in the biotechnology and pharmaceutical industries, has been elected to its Board of Directors at its Annual Meeting of Stockholders held earlier today. Mr....
NLS Pharmaceutics Ltd. a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central nervous system disorders, and Kadimastem Ltd. ("Kadimastem") (TASE: KDST), a...
PharmaScroll's comprehensive suite of services is meticulously designed to meet the evolving needs of the pharmaceutical market. By aligning with emerging trends and challenges, the firm ensures its clients receive cutting-edge solutions that drive...
is a Canadian life sciences tools company specializing in innovative biosensor technology for the academic and biopharmaceutical sectors. In their mission to improve human life, Nicoya provides scientists with user-friendly and integrated solutions...
of Merck KGaA, Darmstadt, Germany is a proven leader in terms of the breadth and quality of products they offer for pharmaceutical development and manufacturing, and we’re excited to combine that with our ability to provide world-class automation,...
Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous dose-limiting toxicity, announced that it has secured a $30 million financing to advance the development of LUT014, an...
our clients and the communities we serve. About Secretome Therapeutics: Secretome Therapeutics is a clinical-stage biopharmaceutical company pioneering the development of therapeutics derived from neonatal cardiac progenitor cells (nCPC) to treat...
West Pharmaceutical Services, Inc. a global leader in innovative solutions for injectable drug administration, announced the introduction of Daikyo PLASCAP® Ready-to-Use Validated (RUV) closures in a new nested format available in multiple...
and cost-effective vaccine to prevent malaria is desperately needed. HDT Bio Corp. is a clinical-stage biopharmaceutical company specializing in advanced RNA vaccine technologies, including the company's proprietary LION nanoparticle delivery...
Platinum. It introduces advanced features specifically tailored to address the evolving needs of researchers and biopharmaceutical customers. Its key innovations include: Streamlined User Experience: Platinum Pro features an enlarged touchscreen...
experience in sales, business development, and go-to-market strategies within the life sciences, healthcare, and biopharmaceutical industries. Previously, Jason led the global sales strategy for Trane Technologies' Life Science Solutions Team,...
shortening timelines for bringing new therapies and vaccines to market and empowering researchers, biotech, and pharmaceutical companies to make personalized medicine a reality. “Our team has worked closely with NTx and utilized the innovative...
as Chief Operating Officer (COO). With almost three decades in the biopharma industry working at leading global pharmaceutical companies, Dr. Leighton brings a wealth of experience in manufacturing, supply chain operations and commercial strategy....
its potential to accelerate the development of orally available cyclic peptide drugs, potentially transforming the pharmaceutical industry's approach to challenging targets. This breakthrough in cyclic peptide design for β-catenin showcases the...
NLS Pharmaceutics Ltd. a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central nervous system disorders, and Kadimastem Ltd. "Kadimastem", a clinical-stage cell...
Cardurion Pharmaceuticals, Inc. a clinical-stage biotechnology company discovering and developing new therapeutic approaches for the treatment of cardiovascular diseases, today announced that Charlotte (Charlie) Newman has joined the company as...
